Clinical trial design and patient recruitment is inefficient and expensive for both academia and industry. Penn Medicine is participating in TriNetX, a global provider, pharma and CRO data network to advance our feasibility and recruitment capabilities with the goal of bringing new therapies to our patients faster.

TriNetX enables researchers to:

  •          Design efficient protocols with inclusion and exclusion criteria using real world patient data
  •          Find and recruit patients that match protocols
  •          Attract sponsored studies from leading pharma and CROs
  •          Collaborate with peer academic institutions through shared access to patient populations

If you already have access, you can login here.